SNX27
protein-codingsorting nexin 27, the group of Sorting nexins|PDZ domain containing
Gene summary
This gene encodes a member of the sorting nexin family, a diverse group of cytoplasmic and membrane-associated proteins involved in endocytosis of plasma membrane receptors and protein trafficking through these compartments. All members of this protein family contain a phosphoinositide binding domain (PX domain). A highly similar protein in mouse is responsible for the specific recruitment of an isoform of serotonin 5-hydroxytryptamine 4 receptor into early endosomes, suggesting the analogous role for the human protein. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~87.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: LiferaOmics
Genetic evidence – Published PMID: 25894286 – Family 1 – one proband (four affected siblings reported). Case-level (biallelic predicted null in AR model; homozygous frameshift; consanguinity −0.5 applied) = (1.5 − 0.5) = 1.0; Segregation (multiple affected sibs with consistent genotype; conservative assignment) = 0.5 Case-control = 0 Family 1 total = 1.5 PMID: 31721175 – Family 2 – one proband. Case-level (AR compound heterozygous; one truncating + one non-LOF ; each variant evaluated independently; no consanguinity deduction applied) = 1.6; Segregation = 0 Case-control = 0 Family 2 total = 1.6 PMID: 31721175 – Family 3 – one proband. Case-level (AR compound heterozygous; one truncating + one non-LOF ; each variant evaluated independently; no consanguinity deduction applied) = 1.6; Segregation = 0 Case-control = 0 Family 3 total = 1.6 Published genetic evidence total = 1.5 + 1.6 + 1.6 = 4.7 / 12 Genetic evidence – Our cases Family 1 – One proband. Case-level (pLOF; homozygous; consanguinity −0.5 applied) = (1.5− 0.5) = 1.0; Segregation = 0; Case-control = 0 Case-control = 0 Family 1 total = 1.0 Family 2 – One proband. Case-level (pLOF; homozygous; consanguinity −0.5 applied) = (1.5− 0.5) = 1.0; Segregation = 0; Case-control = 0 Family 2 total = 1.0 Family 3 – One proband. Case-level (pLOF; homozygous; no-consanguinity) = 1.5; Segregation = 0; Case-control = 0; Segregation = 0 Case-control = 0 Family 3 total = 1.5 Our genetic evidence total = 1.0 + 1.0+ 1.5 = 3.5 / 12 Total genetic evidence (published AR + our cases) 4.7 (published AR) + 3.5 (our cases) = 8.2 / 12 Experimental evidence – Published PMID: 25894286 – Patient fibroblasts demonstrate absence of SNX27 protein, supporting pathogenic loss of function. Functional alteration (patient-derived cells) = 1.0 PMID: 21300787 – Snx27 deficiency in mice results in growth retardation and implicates NMDA receptor trafficking defects. Non-human model (supportive, not full phenotypic recapitulation) = 0.5 PMID: 23524343 – Loss of SNX27 disrupts glutamate receptor recycling and causes excitatory synaptic dysfunction. Gene function / biological plausibility = 0.5 Experimental evidence total = 2.0 / 6 Overall score Genetic evidence = 8.2 Experimental evidence = 2.0 Overall score = 10.2 / 18
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SNX27 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001330723.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 137 | 2 | 142 | ||
| missense | 2 | 1 | 177 | 6 | 186 | |
| nonsense | 8 | 1 | 1 | 10 | ||
| start loss | 0 | |||||
| frameshift | 8 | 2 | 1 | 11 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 5 | |||
| Total | 18 | 5 | 186 | 143 | 2 | 354 |
Highest pathogenic variant AF is 0.000023170871
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001317652.1 | 12 | MANE Select | |
| Ensembl | ENSP00000400333.2 | 12 | MANE Select | |
| RefSeq | NP_001424530.1 | 11 | Standard | |
| RefSeq | NP_001424531.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- establishment of natural killer cell polarity
- intracellular protein transport
- signal transduction
- endosome to lysosome transport
- endosomal transport
Molecular Function
- protein binding
- phosphatidylinositol-3-phosphate binding
- phosphatidylinositol binding
Cellular Component
- immunological synapse
- nucleoplasm
- endosome
- early endosome
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000368843
- Coding exons
- 12
- Length
- 87027
- Individuals with no LoFs
- 125731
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 17
- Defined
- 125748
- p
- 0.0000676
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.17 | 179 | 282 | 0.636 | 0.0000152 | 3433 |
| Missense (PolyPhen) | 67 | 114.26 | 0.58636 | 1337 | ||
| Synonymous | 1.58 | 92 | 113 | 0.811 | 0.00000666 | 996 |
| Loss of Function | 4.98 | 2 | 32.8 | 0.0610 | 0.00000205 | 345 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the retrograde transport from endosome to plasma membrane, a trafficking pathway that promotes the recycling of internalized transmembrane proteins. Following internalization, endocytosed transmembrane proteins are delivered to early endosomes and recycled to the plasma membrane instead of being degraded in lysosomes. SNX27 specifically binds and directs sorting of a subset of transmembrane proteins containing a PDZ- binding motif at the C-terminus: following interaction with target transmembrane proteins, associates with the retromer complex, preventing entry into the lysosomal pathway, and promotes retromer-tubule based plasma membrane recycling. SNX27 also binds with the WASH complex. Interacts with membranes containing phosphatidylinositol-3-phosphate (PtdIns(3P)). May participate in establishment of natural killer cell polarity. Recruits CYTIP to early endosomes. {ECO:0000269|PubMed:17351151, ECO:0000269|PubMed:20733053, ECO:0000269|PubMed:21300787, ECO:0000269|PubMed:21303929, ECO:0000269|PubMed:21602791, ECO:0000269|PubMed:21926430, ECO:0000269|PubMed:22411990, ECO:0000269|PubMed:23563491}.;
Recessive Scores
- pRec
- 0.0851
Intolerance Scores
- LoFtool
- 0.118
- RVIS EVS
- 0.06
- RVIS percentile EVS
- 58.53
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.890
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |